First Republic Investment Management, Inc. Galapagos Nv Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $400,834 - $485,122	-5,821 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$76.15 - $111.94 $24,977 - $36,716	-328 Reduced 5.33%	5,821 $449,000
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $161,545 - $247,281	1,668 Added 37.22%	6,149 $609,000
Q3 2020 Nov 12, 2020	BUY	$122.47 - $213.56 $548,788 - $956,962	4,481 New	4,481 $636,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

Bvf Inc San Francisco, CA

1.57M
Shares

$45.2 Million
1.44% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.41M
Shares

$40.6 Million
0.76% of portfolio
Prosight Management, LP Dallas, TX

1.03M
Shares

$29.6 Million
7.95% of portfolio
Logos Global Management LP San Francisco, CA

800K
Shares

$23 Million
3.05% of portfolio
Primecap Management CO Pasadena, CA

720K
Shares

$20.7 Million
0.02% of portfolio

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account